Fagron SA (ARSUF)
18.59
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Fagron Shareholders Equity (Quarterly): 512.60M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 512.60M |
| June 30, 2023 | 474.22M |
| June 30, 2023 | 474.22M |
| December 31, 2022 | 433.83M |
| June 30, 2022 | 388.44M |
| June 30, 2022 | 388.44M |
| December 31, 2021 | 362.86M |
| June 30, 2021 | 342.08M |
| June 30, 2021 | 342.08M |
| December 31, 2020 | 311.78M |
| June 30, 2020 | 255.12M |
| June 30, 2020 | 255.12M |
| December 31, 2019 | 271.53M |
| June 30, 2019 | 243.38M |
| June 30, 2019 | 243.38M |
| December 31, 2018 | 235.89M |
| June 30, 2018 | 207.55M |
| June 30, 2018 | 207.55M |
| December 31, 2017 | 218.08M |
| June 30, 2017 | 184.58M |
| June 30, 2017 | 184.58M |
| Date | Value |
|---|---|
| December 31, 2016 | 158.75M |
| June 30, 2016 | 110.47M |
| June 30, 2016 | 110.47M |
| December 31, 2015 | -73.36M |
| June 30, 2015 | 189.52M |
| June 30, 2015 | 189.52M |
| December 31, 2014 | 188.49M |
| June 30, 2014 | 205.04M |
| June 30, 2014 | 205.04M |
| December 31, 2013 | 211.45M |
| June 30, 2013 | 294.05M |
| June 30, 2013 | 294.05M |
| December 31, 2012 | 319.29M |
| June 30, 2012 | 271.16M |
| June 30, 2012 | 271.16M |
| December 31, 2011 | 282.39M |
| June 30, 2011 | 301.89M |
| December 31, 2010 | 273.76M |
| June 30, 2010 | 235.67M |
| December 31, 2009 | 277.86M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
243.38M
Minimum
Jun 2019
512.60M
Maximum
Dec 2023
353.27M
Average
342.08M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 146.75M |
| ProQR Therapeutics NV | 37.60M |
| Merus NV | 349.45M |
| argenx SE | -- |
| Pharming Group | 205.94M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.113B |
| Total Liabilities (Quarterly) | 596.17M |
| Debt to Equity Ratio | 0.7009 |
| Current Ratio | 1.917 |
| Net Debt Paydown Yield | 0.92% |